CNO Financial Group, Inc.
NYSE:CNOInsurance - Life
+$0.03 today
- Market cap
- $5.14B
- Beta
- 0.84
- P/E (TTM)
- 19.6
- EPS (TTM)
- $2.61
- Dividend yield
- 1.35%
Volume 0.67M
Average 0.71M
CNO Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
CNO Financial Group, Inc.NYSE: CNO
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 68.4% from a year ago
Cash & equivalents stood at $1.29B at the end of Q2 FY2026, up 68.4% from a year earlier and up 14.2% from the prior quarter. Over 3 fiscal years it compounded at +140.0% a year.
Context
- Cash & equivalents amounted to 3.2% of total assets at the end of Q2 FY2026, up 1.2 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +68.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 956.1M USD
- Year-over-year change
- -42.3%
- 4-year CAGR
- +76.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 956.1M | -42.3% |
| FY2024 | 2024-12-31 | 1.66B | +113.9% |
| FY2023 | 2023-12-31 | 774.5M | +1019.2% |
| FY2022 | 2022-12-31 | 69.2M | -30.5% |
| FY2021 | 2021-12-31 | 99.6M | — |
Cash & Equivalents vs competitors
How CNO compares with its peers on the latest reported figures
- CNO's Jun 2026 cash & equivalents of $1.29B is the 4th highest of the 9 companies compared; the peer median is $264.36M.
- Its year-over-year change of +68.4% is the 2nd highest of 9, against a peer median of +11.1%.
- Cash & equivalents amounts to 3.2% of total assets for CNO, versus a peer median of 1.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $8.53B | +29.1% | +9.4% | 3.6% | |
| Jun 2026 | $2.1B | +11.6% | +15.7% | 2.0% | |
| Jun 2026 | $1.99B | +10.5% | +4.2% | 2.3% | |
| Jun 2026 | $1.29B | +68.4% | +140.0% | 3.2% | |
| Jun 2026 | $301.73M | -18.7% | +20.1% | 12.9% | |
| Sep 2026 | $227M | +44.6% | +53.6% | 1.8% | |
| Sep 2026 | $195.09M | -93.6% | -25.2% | 0.6% | |
| Sep 2026 | $122.42M | -90.8% | -51.1% | 0.7% | |
| Sep 2026 | $51.53M | +118.2% | +26.1% | 0.6% | |
| Peer median (excluding CNO) | $264.36M | +11.1% | +12.5% | 1.9% | |
Competitors are the stored peer set for CNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 99.6M | 69.2M | 774.5M | 1.66B | 956.1M |
| Short-term Investments | 25.03B | 20.56B | 21.51B | 23.03B | 7.92B |
| Net Receivables | 4.69B | 5.52B | 4.98B | 4.96B | 4.68B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 632.1M | 575.7M | (27.26B) | 341M | 27.4M |
| Total Current Assets | 30.45B | 26.73B | 0 | 29.99B | 13.58B |
| Property, Plant & Equipment (Net) | 0 | 0 | 85.3M | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.33B | 1.97B | 2.13B | 2.32B | 2.54B |
| Long-term Investments | 3.89B | 3.78B | (20.74B) | 4.84B | 22.08B |
| Tax Assets | 0 | 0 | 1.14B | 0 | 0 |
| Other Non-current Assets | 523M | 648.8M | 52.42B | 703.2M | 590.9M |
| Total Non-current Assets | 5.75B | 6.4B | 35.03B | 7.86B | 25.21B |
| Total Assets | 36.2B | 33.13B | 35.03B | 37.85B | 38.79B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 8.4M | 0 | 936.2M | 0 | 0 |
| Deferred Revenue | 246.7M | 235M | 0 | 226.8M | 228M |
| Other Current Liabilities | 13.69B | 15.23B | 0 | 17.59B | 18.91B |
| Total Current Liabilities | 13.94B | 15.47B | 0 | 17.82B | 19.14B |
| Long-term Debt | 4B | 3.88B | 4.15B | 4.52B | 4.05B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 13.01B | 12.01B | 28.66B | 12.99B | 12.96B |
| Total Non-current Liabilities | 17.01B | 15.9B | 32.81B | 17.51B | 17.01B |
| Total Liabilities | 30.94B | 31.36B | 32.81B | 35.33B | 36.15B |
| Common Stock | 1.2M | 1.1M | 1.1M | 1M | 900K |
| Retained Earnings | 1.13B | 1.69B | 1.9B | 2.25B | 2.42B |
| Accumulated OCI | 1.95B | (1.96B) | (1.58B) | (1.37B) | (1.12B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 5.26B | 1.77B | 2.22B | 2.52B | 2.64B |
| Total Debt | 4B | 3.88B | 4.15B | 4.52B | 4.05B |
| Net Debt | 3.9B | 3.81B | 3.38B | 2.86B | 3.1B |
CNO Financial Group, Inc.
NYSE:CNO
Intrinsic Alpha fair value
Locked
Current Price
$56.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.